NCT07446257 2026-03-03
THIO and Cadonilimab in Resectable Hepatocellular Carcinoma
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Not yet recruiting
Clinical Trials
26 trialsNCT07318389 2026-02-27
ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Not yet recruiting
NCT07420010 2026-02-19
An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.
Zhejiang University
Phase EARLY_PHASE1 Not yet recruiting
NCT07394205 2026-02-06
Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer
First Affiliated Hospital of Wenzhou Medical University
Phase EARLY_PHASE1 Not yet recruiting
NCT07389525 2026-02-05
Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study
Indiana University
Phase EARLY_PHASE1 Not yet recruiting
NCT06824363 2026-01-30
ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu
University of California, Irvine
Phase EARLY_PHASE1 Not yet recruiting
NCT06828588 2026-01-29
Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Not yet recruiting
NCT07231094 2025-11-17
A Clinical Study Evaluating the Safety, Tolerability, Preliminary Efficacy and Immunogenicity of a Tumor Vaccine Injection Targeting Stressinducible Proteins MICA/B in Combination With the AG Regimen in Patients With Metastatic Pancreatic Cancer
The Third Xiangya Hospital of Central South University
Phase EARLY_PHASE1 Not yet recruiting
NCT07166263 2025-09-10
Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer
Base Therapeutics (Shanghai) Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT07033689 2025-08-14
Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)
SONIRE Therapeutics Inc.
Phase EARLY_PHASE1 Not yet recruiting
NCT07026981 2025-08-08
[Ga-68]MTP220 PET for Biodistribution and Efficacy in Pancreatic Cancer and Head and Neck Cancers
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Not yet recruiting
NCT07089940 2025-07-29
OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Not yet recruiting
NCT06931873 2025-04-17
Neoadjuvant Radiochemotherapy Combined With QL1706 for Low Rectal Cancer
Changhai Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT06887673 2025-03-20
Lipid Mediators & Cancer: Montelukast, SPM, and Almonds
University of South Florida
Phase EARLY_PHASE1 Not yet recruiting
NCT06756295 2025-03-12
FAST-CR
The University of Hong Kong-Shenzhen Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT06646783 2024-10-17
Phase IIT Trial of SNA014
SmartNuclide Biopharma
Phase EARLY_PHASE1 Not yet recruiting
NCT06645301 2024-10-16
BGT007 Treatment for Recurrent/refractory Gastrointestinal Malignancies
BioSyngen Pte Ltd
Phase EARLY_PHASE1 Not yet recruiting
NCT06645314 2024-10-16
Study on the Safety and Efficacy of BST06 Injection in the Treatment of Advanced Hepatocellular Carcinoma
BioSyngen Pte Ltd
Phase EARLY_PHASE1 Not yet recruiting
NCT06619886 2024-10-01
TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1 Not yet recruiting
NCT06525714 2024-07-31
Effect of HIPEC After Radical Surgery on Long-term Survival for Locally Advanced Gastric Cancer
The First Hospital of Jilin University
Phase EARLY_PHASE1 Not yet recruiting
NCT06434376 2024-05-30
MRD-positive Colorectal Cancer Patients Combined With Personalized Immune Regulation Diagnosis
Second Affiliated Hospital of Wenzhou Medical University
Phase EARLY_PHASE1 Not yet recruiting
NCT06432075 2024-05-29
Neoantigen Reactive T Cells c for Chinese Patients With Advanced Gastric Cancer
First Affiliated Hospital of Wenzhou Medical University
Phase EARLY_PHASE1 Not yet recruiting
NCT06364800 2024-04-15
Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal Antibody
Beijing 302 Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT06196658 2024-01-09
Early Phase I Study of Autologous T Cells (EX02 CAR-T) for Unresectable Pancreatic/Bile Duct Cancer
First People's Hospital of Hangzhou
Phase EARLY_PHASE1 Not yet recruiting
NCT06156267 2023-12-05
Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino
Fudan University
Phase EARLY_PHASE1 Not yet recruiting
NCT05447234 2023-02-16
TCRx_T Cells for Advanced or Recurrent Gastric/Gastroesophageal Junction Cancer After Failure of First Chemotherapy
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase EARLY_PHASE1 Not yet recruiting